Summary
Prophylactic treatment of emergence Vomiting and restlessness is considered to be indicated when these complications will endanger the patient's life or the operative site. This is particularly the case in plastic and ophthalmic surgery and in patients suffering from coronary arterial insufficiency. The cautious, intravenous administration of triflupromazine in dosage 0.1-1.0 mg./10 lb. body weight prior to the termination of anaesthesia reduced the incidence of these complications. Significant depression of the blood pressure was unusual and when it did occur was unrelated to the dosage used.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cullen, Stuart C. What Price Tranquillization. Anesthesiology20: 697 (1959).
Dreyfuss, F. Role of Emotional Stress Preceding Coronary Occlusion. Am. J. Cardiol.3: 590 (1959).
Sharpey-Schafer, E. P. Mechanism of Acute Hypotension from Fear or Nausea Brit. Med. J.2: 878 (1958).
Davies, J. I., Hansen, J. M., &Angell, S. M. Triflupromazine (Vesprin) in Anaesthesia: A Clinical Evaluation. Canad. Anaesth. Soc. J.6: 375 (1959).
Rights and permissions
About this article
Cite this article
McIntyre, J.W.R. Ataractics and the recovery ijoom, with reference to triflupromaizine, I. Can. Anaes. Soc. J. 7, 176–178 (1960). https://doi.org/10.1007/BF03021221
Issue Date:
DOI: https://doi.org/10.1007/BF03021221